CollimateHealth develops a clinically scalable microbeam radiation technology designed to reshape the way cancer is treated. While conventional radiation oncology typically relies on broad and lower-dose beams that cause significant side effects, microbeam radiation delivers an array of extremely narrow, micrometer-scale beams at substantially higher dose.
Total raised: $6.97M
Investors 1
| Date | Name | Website |
| 13.09.2026 | Positron V... | positron.v... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 15.06.2026 | Seed | $6.97M | - |
Mentions in press and media 3
| Date | Title | Description |
| 15.06.2026 | CollimateHealth Raises €6M in Seed Funding | CollimateHealth, a Munich, Germany-based life sciences startup which specializes in radiation therapies, raised €6M in Seed funding. Backers included VP Venture Partners, Positron, XISTA Science Ventures, High-TechGründerfonds (HTGF) and ca... |
| 15.06.2026 | CollimateHealth Raises $6.9 Million Seed Round To Advance Microbeam Radiation Therapy For Cancer Treatment | CollimateHealth announced the closing of an oversubscribed €6 million (about $6.9 million) seed funding round as the company seeks to advance its proprietary microbeam radiation therapy technology and transform the future of oncology. The f... |
| - | CollimateHealth | “CollimateHealth” |